20 years of Biosimilars: Are We on the Right Track?
The Science Huddle – 20 years of Biosimilars: Are We on the Right Track?
For nearly 20 years, biosimilars have been at the center of a great debate with 2022 seen as a pivotal point as more of these biologic similars came to market. The debate has progressed from viability and feasibility to sustainability with cost, regulatory guidelines, incentives, efficacy, and patent expirations at the center of today’s industry discussion. As more biosimilars prove they can deliver new competition and lower costs to patient-critical treatments, the dialogue is shifting.
Join this lively discussion on the challenges and opportunities that biosimilars present and learn more about the speakers’ perspectives as they explore the newest thinking, latest strategies, and next steps for improving biosimilar access and uptake.
Event Panelists:
• Leah Christi, PhD, Executive Director, Amgen – Global Biosimilars Regulatory Affairs and Regulatory & R&D Policy
• Martin Schiestl, Global Head Regulatory Affairs Policy, Sandoz Biopharmaceuticals
• Elena Wolff-Holz, Global Head Clinical Development, Biocon Biologics.
Event Moderator:
• Dr. Christian Schneider, Vice President, Head of Biopharma Excellence and Chief Medical Officer (Biopharma), at PharmaLex
* PharmaLex GmbH is a subsidiary of Cencora, Inc. The discussion by the panelists and the opinions expressed during the webinar are solely the opinions of the participants and do not represent the opinions of PharmaLex or Cencora, Inc. or any other entity. PharmaLex GmbH and Cencora strongly encourage listeners to review all available information about the discussion topics and to rely on their own experience and expertise in making decisions related thereto.
PharmaLex GmbH is a subsidiary of Cencora, Inc. The discussion by the panelists and the opinions expressed during the webinar are solely the opinions of the participants and do not represent the opinions of PharmaLex or Cencora, Inc. or any other entity. PharmaLex GmbH and Cencora strongly encourage listeners to review all available information about the discussion topics and to rely on their own experience and expertise in making decisions related thereto.
